Breast Cancer Update, Issue 2, 2016 (Video Program) - Video 4


Management of the axilla in patients with HER2-positive BC converted from clinically node-positive to node-negative after neoadjuvant therapy
2:20 minutes.

Early-stage breast cancer (BC) in the adjuvant and neoadjuvant settings

Genomic assays and (neo)adjuvant treatment decision-making

Management of metastatic BC (mBC)

CDK4/6 inhibitors for the treatment of BC

Novel approaches under investigation in BC